Insider · CIK 0001431818

ProQuest Investments IV, L.P.

CIK 0001431818 Name as filed on the most recent filing

Filed as ProQuest Investments IV, L.P. (34)

124 transaction lines · from 34 filings · filed 2009-12-18 to 2017-11-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-09-07 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 1,370, disposed Open Form 4 filing 0000932440-16-000471
2016-09-06 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 4 lines 1,595,904, disposed Open Form 4 filing 0000932440-16-000471
2016-08-24 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 3 lines 728,562, disposed Open Form 4 filing 0000932440-16-000465
2016-08-23 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 3 lines 1,090,109, disposed Open Form 4 filing 0000932440-16-000465
2016-08-17 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 4 lines 897,619, disposed Open Form 4 filing 0000932440-16-000458
2016-08-16 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 5 lines 3,709,391, disposed Open Form 4 filing 0000932440-16-000458
2016-08-15 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 4 lines 1,516,160, disposed Open Form 4 filing 0000932440-16-000458
2016-05-13 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 572,062, disposed Open Form 4 filing 0000932440-16-000387
2016-05-12 S, Open-market sale Eagle Pharmaceuticals, Inc.EGRX 160,000, disposed Open Form 4 filing 0000932440-16-000387
2016-01-27 P, Open-market purchase Agile Therapeutics IncAGRX 2,499,995, acquired Open Form 4 filing 0000932440-16-000309
2015-05-12 S, Open-market sale Immune Design Corp.IMDZ 2 lines 3,835,732, disposed Open Form 4 filing 0000932440-15-000159
2015-04-24 S, Open-market sale Immune Design Corp.IMDZ 666,000, disposed Open Form 4 filing 0000932440-15-000142
2015-04-23 S, Open-market sale Immune Design Corp.IMDZ 2 lines 885,686, disposed Open Form 4 filing 0000932440-15-000142
2015-04-22 S, Open-market sale Immune Design Corp.IMDZ 670,613, disposed Open Form 4 filing 0000932440-15-000142
2015-04-21 S, Open-market sale Immune Design Corp.IMDZ 373,300, disposed Open Form 4 filing 0000932440-15-000135
2015-04-20 S, Open-market sale Immune Design Corp.IMDZ 338,220, disposed Open Form 4 filing 0000932440-15-000135
2015-04-17 S, Open-market sale Immune Design Corp.IMDZ 503,023, disposed Open Form 4 filing 0000932440-15-000135
2015-04-16 S, Open-market sale Immune Design Corp.IMDZ 2,675, disposed Open Form 4 filing 0000932440-15-000131
2015-04-15 S, Open-market sale Immune Design Corp.IMDZ 2 lines 1,142,860, disposed Open Form 4 filing 0000932440-15-000131
2015-04-14 S, Open-market sale Immune Design Corp.IMDZ 376,570, disposed Open Form 4 filing 0000932440-15-000131
2015-04-07 S, Open-market sale Immune Design Corp.IMDZ 95,580, disposed Open Form 4 filing 0000932440-15-000129
2015-04-06 S, Open-market sale Immune Design Corp.IMDZ 104,698, disposed Open Form 4 filing 0000932440-15-000129
2015-04-01 S, Open-market sale Immune Design Corp.IMDZ 3 lines 1,647,148, disposed Open Form 4 filing 0000932440-15-000125
2015-03-25 S, Open-market sale Immune Design Corp.IMDZ 136,587, disposed Open Form 4 filing 0000932440-15-000117
2015-03-24 S, Open-market sale Immune Design Corp.IMDZ 365,244, disposed Open Form 4 filing 0000932440-15-000117
2015-03-23 S, Open-market sale Immune Design Corp.IMDZ 138,900, disposed Open Form 4 filing 0000932440-15-000107
2015-03-20 S, Open-market sale Immune Design Corp.IMDZ 238,749, disposed Open Form 4 filing 0000932440-15-000107
2015-03-20 S, Open-market sale Immune Design Corp.IMDZ 11,252, disposed Open Form 4 filing 0000932440-15-000107

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ProQuest Investments IV, L.P., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001431818

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.